Stoke Therapeutics (STOK) PT Raised to $49 at Credit Suisse
Tweet
Share
E-mailGet Alerts STOK Hot Sheet
Price: $25.29 --0%
Rating Summary:
14 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 18
Rating Summary:
14 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 18
Join SI Premium – FREE
Credit Suisse analyst Martin Auster raised the price target on Stoke Therapeutics (NASDAQ: STOK) to $49.00 (from $42.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Acadia Pharmaceuticals (ACAD) PT Lowered to $35 at Needham
- Costco Wholesale (COST) PT Lowered to $1,015 at JPMorgan
- Smiths Group (SMIN:LN) (SMGKF) PT Raised to GBP31.50 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
